H.R. 1715: Public Health Funding Restoration Act
This bill, titled the Public Health Funding Restoration Act, aims to restore funding for the Prevention and Public Health Fund established under the Affordable Care Act. Here are the key elements of the bill:
Purpose
The bill seeks to ensure a sustained national investment in public health programs that focus on prevention. The overarching goal is to improve public health and help manage and reduce healthcare costs in the long run.
Funding Provisions
The bill proposes to restore the funding level of the Prevention and Public Health Fund to $2 billion annually. This funding will support vital health initiatives and allow for a broader response to health threats.
Importance of Funding
- The Prevention and Public Health Fund is seen as critical for various efforts by the Department of Health and Human Services, as well as for state and local health departments.
- These funds help in controlling infectious diseases, preventing chronic conditions, and promoting initiatives such as tobacco cessation, mental health support, and immunizations.
Cost-Effectiveness
The bill highlights the effectiveness of investing in prevention, indicating that every dollar spent on public health prevention can save considerably more in future healthcare costs. For example:
- A dollar spent on prevention can save nearly $6 in healthcare spending.
- A dollar spent on childhood vaccines is projected to save $16.50 in future healthcare costs.
Expected Outcomes
Restoring the funding aims to:
- Enhance public health programs that can reduce rates of illnesses like cancer, diabetes, and heart disease.
- Allow for better responses to public health crises, including pandemics.
- Ensure necessary resources for vaccination distribution and public health information dissemination.
Continued Investment
The bill asserts that consistent funding is crucial to maintain and expand successful public health programs that have demonstrated effectiveness. This includes programs run by the Centers for Disease Control and Prevention (CDC) and local health departments that tackle unique health challenges faced by communities.
Legislative Status
The bill was introduced on February 27, 2025, and is currently under consideration in the House of Representatives.
Relevant Companies
- PFE (Pfizer Inc.): As a leading pharmaceutical company, Pfizer could see increased demand for its vaccines and public health products if funding for immunization programs is restored.
- MRK (Merck & Co., Inc.): Merck, known for its vaccines and health initiatives, may benefit from enhanced public health investment, particularly in the realm of immunizations and disease prevention programs.
- JNJ (Johnson & Johnson): This company is involved in various health and prevention efforts; increased funding could support its vaccination and health awareness campaigns.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
35 bill sponsors
-
TrackDoris O. Matsui
Sponsor
-
TrackNanette Diaz Barragán
Co-Sponsor
-
TrackKathy Castor
Co-Sponsor
-
TrackSheila Cherfilus-McCormick
Co-Sponsor
-
TrackGilbert Ray Cisneros, Jr.
Co-Sponsor
-
TrackYvette D. Clarke
Co-Sponsor
-
TrackSteve Cohen
Co-Sponsor
-
TrackGerald E. Connolly
Co-Sponsor
-
TrackSharice Davids
Co-Sponsor
-
TrackDebbie Dingell
Co-Sponsor
-
TrackSarah Elfreth
Co-Sponsor
-
TrackRobert Garcia
Co-Sponsor
-
TrackAl Green
Co-Sponsor
-
TrackRaúl M. Grijalva
Co-Sponsor
-
TrackPramila Jayapal
Co-Sponsor
-
TrackJulie Johnson
Co-Sponsor
-
TrackHenry C. "Hank" Johnson, Jr.
Co-Sponsor
-
TrackRobin L. Kelly
Co-Sponsor
-
TrackRo Khanna
Co-Sponsor
-
TrackRaja Krishnamoorthi
Co-Sponsor
-
TrackSarah McBride
Co-Sponsor
-
TrackJennifer L. McClellan
Co-Sponsor
-
TrackSeth Moulton
Co-Sponsor
-
TrackKevin Mullin
Co-Sponsor
-
TrackEleanor Holmes Norton
Co-Sponsor
-
TrackDeborah K. Ross
Co-Sponsor
-
TrackTerri A. Sewell
Co-Sponsor
-
TrackMikie Sherrill
Co-Sponsor
-
TrackShri Thanedar
Co-Sponsor
-
TrackDina Titus
Co-Sponsor
-
TrackRashida Tlaib
Co-Sponsor
-
TrackJill N. Tokuda
Co-Sponsor
-
TrackPaul Tonko
Co-Sponsor
-
TrackNydia M. Velázquez
Co-Sponsor
-
TrackDebbie Wasserman Schultz
Co-Sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Feb. 27, 2025 | Introduced in House |
| Feb. 27, 2025 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
